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Background: Photodynamic therapy is an alternative treatment of muco-cutaneous tumors that uses a light source
able to photoactivate a chemical compound that acts as a photosensitizer. The phthalocyanines append to a wide
chemical class that encompasses a large range of compounds; out of them aluminium-substituted disulphonated
phthalocyanine possesses a good photosensitizing potential.
Results: The destructive effects of PDT with aluminium-substituted disulphonated phthalocyanine are achieved by
induction of apoptosis in tumoral cells as assessed by flow cytometry analysis. Using protein microarray we evaluate
the possible molecular pathways by which photodynamic therapy activates apoptosis in dysplastic oral keratinocytes
cells, leading to the tumoral cells destruction. Among assessed analytes, Bcl-2, P70S6K kinase, Raf-1 and Bad proteins
represent the apoptosis related biomolecules that showed expression variations with the greatest amplitude.
Conclusions: Up to date, the intimate molecular apoptotic mechanisms activated by photodynamic therapy with this
type of phthalocyanine in dysplastic human oral keratinocytes are not completely elucidated. With protein microarray
as high-throughput proteomic approach a better understanding of the manner in which photodynamic therapy leads
to tumoral cell destruction can be obtained, by depicting apoptotic molecules that can be potentially triggered in
future anti-tumoral therapies.
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Photodynamic therapy (PDT) is a therapeutical approach
directed towards destruction of tumoral cells, with
increasing use in various medical fields such as urology,
gastroenterology, pneumology and ophthalmology. The
anti-tumoral effect of PDT is widely used in dermatology,
in the treatment of several muco-cutaneous tumors, such
as basal and squamous cell carcinoma, Bowen disease,
leucoplakia and oral dysplasia [1,2].
PDT uses an adequate light source able to photoactivate
a chemical compound that acts like a photosensitiser;
various photosensitizers are recently the subject of intense
research worldwide, mainly porphyrin precursors and* Correspondence: caroconstantin@gmail.com
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chemical structures sharing a four-ring pyrrol-like
aromatic structure similar to a certain extent to that of the
porphyrins; central inclusion of a metal ion such as Al,
Zn, In or Ag modifies the photodynamic properties of
the phthalocyanines (Figure 1). The central metal ion
modulates the photodynamic properties by acting through
the alteration of the electron density in the core of the
compound, increasing π-electron delocalization and
consequently changing the absorbance spectrum of the
substance [4].
Aluminium di-sulphonated phthalocyanine (AlS2Pc) is
a metallo-substituted phthalocyanine with increased
solubility, due to the sulphonated substituents from the
macrocycle periphery. We have previously assessed the
photodynamic properties of AlS2Pc and established itstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 The structure of metallo-sulphonated phthalocyanines
(M =metal; R = SO3-/H).
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PDT [5].
PDT destroys tumoral cells mainly by induction of
apoptosis, the programmed cell death, a complex process
consisting in the activation of multiple intracellular signal-
ing pathways culminating with caspase cascade stimulation
that leads to nuclear dissolution, DNA fragmentation
and lysis of various protein substrates vital to normal cell
physiology. Apoptosis is the result of a genetic encoded pro-
gram activated by various stimuli. Induction of apoptosis in2. Incubation with biological sample
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Figure 2 Protein microarray technology principle.the tumoral cells in a selective manner, without alteration
of the surrounding normal cells is a desired effect that PDT
relies upon and this selective process is achieved by
accumulation of the photosensitizer preferentially in the
tumoral cells. After illumination of the cells containing
the photosensitiser with light of an appropriate wavelength,
the energy provided by the light source is absorbed by
the photosensitiser and consequently discharged in the
medium surrounding the cell, leading to photodynamic
reactions that finally activate apoptosis [1]. The particular
manner in which apoptosis is activated depends of
the cell type and the photosensitiser used in the
process. The mechanistic aspects employed by PDT
using Zn-substituted tri-sulphonated phthalocyanine in
DOK cells have been previously described by us [6].
Protein microarray analysis has started to be increasingly
used in various biomedical applications, but few papers are
published using this technology for evaluating the complex
apoptosis network triggered by PDT therapy. The basic
principle and a schematic workflow for protein microarray
technique are shown in Figure 2. Recently published
5-Aminolevulinic acid (ALA) used to photosensitize
mouse cerebral cortex took advantage of proteomic
antibody microarrays. Using this method 112 proteins were
detected with supposed epigenetic regulation potential.
Among these proteins, the PDT using ALA precursor of
porphyrin induced histone H3 dimethylation as well
as up-regulation of protein Kaiso, a DNA methyl-binding
protein, the overall effect being the suppression of the tran-
scriptional activity in photosensitized cells. This recentd image acquisition 6. Data analysis
Fluorescent spots representing analyte binding to 
printed slide 
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high-throughput results further to be used in therapeutical
approaches. Moreover, this study showed that new
therapeutical targets can be revealed upon assessment
of epigenetic markers [7].
Publications released at the beginning of 2000 focus
only on gene microarray technologies used for apoptosis
quantification post-PDT [8,9], later on transcriptomic
deregulations [10,11] and, only in the last years several
publications focused on protein microarray evaluation,
mainly due to the early stage in which protein-microarray
technology was 10 years ago.
Although a few studies presented the overall pattern
of apoptosis induction in PDT using aluminum di-
sulphonated phthalocyanine [12-14], until now, as to the
best of our knowledge, there are no studies directed to-
wards clarifying the molecular mechanism involved in
the induction of apoptotic cell death following PDT
using AlS2Pc. Such studies could reveal the intimate
mechanisms of apoptosis induction, therefore evaluating
in depth this process other biomolecules can be revealed
as potential targets for enhancing the PDT-apoptosis
effect. For that reason, the presented results aimed to
establish the interrelation of apoptotic proteins that are
activated by PDT using AlS2Pc in DOK cells.
Results and discussion
Apoptosis
In order to prove that the apoptosis mechanisms were in-
duced upon PDT with AlS2Pc we have used flow cytome-
try evaluation of irradiated non-loaded cells (control) and
loaded cells (PDT). From the same cell batches that were
subjected to Protein microarray evaluation, at 1.5 hours
after irradiation protocol, photosensitizer loaded cells
showed a percentage of around 15% cells stained Ann
positive and PI negative (early apoptotic events) and nearly
40% cells staining double positive for PI and Ann (late
apoptotic events) (Figure 3). The finding that upon PDT
mainly late apoptotic events are induced is consistent with
previous data [15]. Moreover, the fact that we have found
that even cellular membrane is affected upon experimental
PDT, as assessed by Ann staining, can either depict the
fact that there are still cells that will enter the late apop-
totic event and/or as previously published [16]. These
types of phthalocyanines can reside in early endosomes
thus hindering per se the membrane architecture, hence
the positivity of annexin staining.
Protein microarray
We have analyzed the apoptosis related biomolecules that
showed the variations with the greatest amplitude (Figure 4).
Anti-apoptotic proteins Bcl-2 (“B-cell lymphoma 2”) and
Bcl-XL (“B-cell lymphoma 2 extra large”) block apoptosis in
usual conditions; their increase inhibits apoptosis, whiletheir variation in the opposite direction facilitates
programmed cell death [17]. This modulator role of
Bcl-2 proteins in cell apoptosis triggered by PDT is
still controversial. The overexpression of Bcl-2 could
either be efficient or abstaining in tumor cells killing
upon experimental PDT, depending on cell type and/or
photosensitizer nature [18].
We have observed a decrease by 64.87% of Bcl-2 level
(p < 0.001), accompanied by a decrease by 45.5% in the
level of Bcl-XL proteins in DOK cells treated with
AlS2Pc and subjected to PDT. Bcl-2 activity is regulated
not only by alteration in the level of protein expression, but
also by various chemical structure alteration carried by sev-
eral enzymes. Bodur et al. have shown in a recent study
[19] that Bcl-2 can be phosphorylated by IKK enzyme
(IkBα-kinase) at a threonine residue located in the 56th
position of the protean chain, leading to a conformational
modification expressed by a decrease in the antiapoptotic
action of Bcl-2, consequently promoting apoptosis. Our ex-
perimental data shows an increase by 11.62% (p = 0.008) of
phospho-Thr 56 Bcl-2 in DOK cells incubated with AlS2Pc
after PDT, as compared to the control cells.
This change in phosphorylated form of Bcl-2 is
connected to the increase in the activity of IKK; usual
substrate of IKK is protein IkBα, the inhibitor of
nuclear factor kb (NFkB); under certain conditions,
IKK phosphorylates IkBα [20]. The activation of IKK
was revealed in the experiment we have carried on by
the finding of 2.287 folds increase of phosphorylated form
of IkBα, altogether with a correspondent decrease of 4.54
folds in the level of dephosphorylated form of IkBα. In a
somewhat related PDT study applied to glioblastoma cells
was assessed by using protein microarray early molecular
events in cells subjected to photosensitizing. Sub-lethal
experimental PDT approach was used in the prior pub-
lished study, where time dependent-, subtle molecular
proteomic events were depicted. The entire group of 224
proteins expressed after this almost non-lethal PDT were
studied. Antibody microarrays showed that in the first
hour of PDT treatment several proteins, such as, protein
kinase Raf, adhesion-related kinases FAK and Pyk2, and
microtubule-associated protein tau are phosphorylated. In
this study Bcl-xL was found over expressed, while caspase
9 down-regulated an overall anti-apoptotic response [21].
The differences in the actual results we are presenting
compared to the previous reported PDT, besides the
different type of cell and PDT photosensitizer resides in
the dose type that is a sub-lethal one in the previous
reported study [21] while in ours we have used lethal doses.
P70S6K kinase is a factor with important roles in protein
synthesis and cell growth. Besides these functions,
p70S6K is involved in apoptosis regulation by phosphor-
ylation of apoptosis enhancer BH3-only protein Bad
(“Bcl-2-associated death promoter”). Bad phosphorylation
AB
Figure 3 Apoptosis evaluation by flow-cytometry of DOK cell line subjected to PDT. A) Apoptosis evaluation for triplicates repeated in four
identical experiments. Annexin V-FITC and PI (red) quantified early, late apoptosis and necrosis: An-Pi- viable cells; An + Pi- early apoptotic cells;
An + Pi + late apoptotic/necrotic cells. Cell samples are from the same batches that were subjected post-irradiation to Protein microarray analysis.
B) Example of flow cytometry registration of un-loaded (control) and loaded cells with AlS2Pc and subjected to PDT.
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teins, explaining p70S6K inhibition of apoptosis [22].
The active form of the p70S6K enzyme is the phosphory-
lated state of the protein. Serine residue in 411 position is
of paramount importance in this process, because in the
absence of its phosphorylation p70S6K cannot be acti-
vated [23]. We have observed an important increase
of more than two folds of the p70S6K dephosphory-
lated form. Alongside, there was a decrease by 54.2%
(p value <0.001) in the level of p70S6K phosphorylated at
Ser411, demonstrating a decline of the p70S6K active
form; whilst p70S6K inhibits apoptosis by Bad phosphor-
ylation. Thus, we can decode the reduction of activated
p70S6K level as a pro-apoptotic effect of AlS2Pc-PDT in
DOK cells.Raf-1 serine-threonine kinase (“cellular-rapidly acceler-
ated fibrosarcoma”, c-Raf) is a protein that plays multiple
key roles in various intracellular signaling processes, as well
as in controlling cell growth and proliferation. Raf-1 is also
involved in apoptosis regulation, by Bad phosphorylation,
with subsequent blocking of Bad protein function [24].
Hence, Raf-1 kinase must be previously activated by phos-
phorylation in order to exert its Bad modulating activity
[25]. We have observed a decrease by 20.45% of the
phosphorylated form of Raf-1 at Ser338, accompanied
by a raise by 31.05% of the non-phosphorylated Raf-1
level (p < 0.001). Taking into consideration that Raf-1
activation promotes cell survival by phosphorylation
and inactivation of Bad protein, the observed alter-
ations in the Raf-1 kinase level forms represent a
AB
Figure 4 Results of protein microarray analysis of the main proteins involved in apoptosis in DOK cells following PDT using AlS2Pc;
mean values and standard deviations are reported, measured in arbitrary fluorescent units. Control cells: un-loaded irradiated DOK cells;
AlS2Pc cells: loaded irradiated DOK cells.
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oral keratinocytes.
Bad is a regulating protein able to dissociate
proapoptotic-antiapoptotic protein dimers, releasing
pro-apoptotic proteins from inhibition exerted by the
anti-apoptotic counterparts Bcl-2 and Bcl-XL. The active
pro-apoptotic form of Bad is the dephosphorylated form,
thus Bad phosphorylation at Ser112 and 136 leads to its
association with 14-3-3 proteins, blocking the Bad
activity [22,26]. We have acknowledged an increase of
4.59 folds of dephosphorylated Bad, accompanied by a
reduction by 59.4% of Bad phosphorylated at Ser112
and 65.3% of Bad phosphorylated at Ser136, data that
consequently proves the involvement of Bad protein
in the induction of apoptosis in DOK cells following
AlS2Pc-PDT. These observations are also consistent
with our previous data regarding the activation status
of Bad [5], as the decrease of Bad phosphorylation
can be attributed to the lack of phosphorylation
(and therefore activation) of p70S6 kinase and Raf-1
kinase.Thus photodynamic therapy using aluminum disul-
phonated phthalocyanine leads to induction of apoptosis
in cultured human dysplastic oral keratinocytes DOK
following a distinctive molecular pathway (Figure 5).
The changes in the level of the main proteins involved
in apoptosis are consistent with apoptosis activation via
intrinsic mitochondrial apoptotic pathway.
Similar to our experimental approach, but using reverse
phase protein microarray in a human urothelial cell lines
model, several apoptotic proteins were found altered upon
PDT. This study has reported that caspase-3 and −9,
HIF-1alpha, Bcl2, Cox2 and the phosphorylated AKT
were enhanced upon PDT with ALA. The authors
point out that, when the cells display a higher differenti-
ation phenotype the apoptotic response is increased, while
lower differentiated cells can have truncated apoptosis
pathways hence their resistance to therapy [27]. This sort
of experimental approach encourage us to evaluate apop-
totic related effects in PDT by a direct phase protein
microarray platform, namely antibody array, that can offer,
in our opinion, a straightforward way for results due to
Figure 5 Molecular mechanisms activated by photodynamic therapy using AlS2Pc in DOK cell line – delineative representation
resulted from protein microarray analysis.
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of the multiple tested analytes along with a rapid
biological interpretation of the data. In addition, the
higher versatility of the platform and reproducibility
counts for the antibody arrays using in tumor research
domain [28]. Reverse phase type of protein microarray is,
as much as used in the biomarker discovery, a specific but
a laborious type of microarray, with lower standardization
and even multiplexing possibilities due to the still low
availability for both detection labeled antibodies and
specific protein antibodies appropriate for the reverse
array platform [29]. In addition, this type of microarrays is
prone to cross-reactivity because all the proteins harbored
by complex cell cultures are investigated. In our experi-
mental approach, the DOK cell line that we have used has
a moderate differentiation stage [30]; therefore the par-
ticularities in the apoptotic biomolecules that we came
across can be explained by the type of cell differentiation.Conclusions
This study is the first one conducted towards elucidation
of the molecular mechanisms activated by AlS2Pc-PDT
in dysplastic keratinocytes using protein microarray
analysis. With this high-throughput array technology,
traditional methods can be overridden in terms of
multiplexing (e.g. ELISA), minimal sample require-
ments and easy quantification of results. Using this
proteomic approach a better understanding of the mannerin which photodynamic therapy leads to tumoral cell
destruction can be obtained, by depicting apoptotic mole-
cules that can be potentially triggered in future anti-
tumoral therapies.
As future perspectives, due to its huge versatility and
enormous possibilities of biomedical applications, the
protein microarray technology is armed with all benefits
for becoming a multiple choice approach for therapy
assessing in clinic. Even if the majority of existing arrays
platforms are dedicated to fundamental research, namely
in biomarkers fields, molecules abundance studies and
biomolecules interactions, the number of platforms
for clinic purposes is currently increasing. In addition,
protein microarray could be an attractive option for
both researchers and clinicians because the platform could
be customized in terms of number and multiplicity of
tested analytes. Molecular changes imprinted by photo-
dynamic treatment in different pathologies are subtle
processes and still incompletely revealed, therefore such a
fine proteomic technology could explore many uncov-
ered intracellular pathways, contributors to en efficient
antitumor host response.Methods
Sensitizer
The procedure of hydroxyaluminum AlS2Pc synthesis has
been adapted according with some previous literature
reports [31,32], and involved two important steps:
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hydroxyaluminum phthalocyanine mixture [(OH)
AlSnPc], n = 1–4) from hydroxyaluminum
phthalocyanine [(OH)AlPc], obtained by the oleum
sulphonation of aluminium phthalocyanine, this final
product being a complex mixture of mono- to
tetrasulphonated derivatives. Briefly, for the
sulphonation process an amount of 30 g (OH)AlPc
was gradually charged to 300 g of 5% fuming sulfuric
acid under constant mixing at 115°C; the reaction
mix was kept at 30°C until the (OH)AlPc was fully
dissolved. Next, the process of sulphonation was
carried out under a nitrogen blanket, with constant
agitation and heated up to 120°C for 30 min. After
the sulphonation process was completed, the
reaction mixture was slowly cooled to room
temperature and subsequently charged with a
drooping funnel into the vigorously agitated mixture
of 2000 g of ice and 1000 g of water. The water
suspension was then filtered with a Buchner funnel,
the filter cake was washed with distilled water until
no sulfate anions were detectable in the filtrate.
Thoroughly washed filter cake of sulphonated (OH)
AlSnPc was dried at 105°C until a constant weight
was attained.
b. The contents of sulphonated (OH)AlSnPc were
determined by column liquid chromatography (LC),
HPLC (high-pressure liquid chromatography) and by
thin layer chromatography (TLC) on Baker SI C18
reverse plates. Separation of each sulphonated
fraction and the mixtures of sulphonated derivatives,
prepared as described above, were performed by LC.
In brief, the chromatographic column was filled with
silica gel (Kieselgel 60 fur die Saulen, Chrom Merck)
and a mixture of ethyl acetate, ethanol and 25%
ammonia water (in the volume ratios 7:4:4) was used
as a mobile phase. The purity of each dry product
was determined by HPLC method, combined with
mass spectrometry, which proved the molecular
constitution of each separated phase. The purities of
the studied (OH)AlS2Pc differing in the relative
positions of the sulphonated groups, namely cis
(the groups attached to the vicinal rings) and trans
(the groups attached to the opposite groups), was
assessed. Currently, there is no method of separating
the two isomers of (OH)AlS2Pc. The purity of each
fraction was: (OH)AlS1Pc - 97.9 (wt.%), (OH)AlS2Pc -
99.4 (wt.%), (OH)AlS3Pc - 98.6 (wt.%) and (OH)
AlS4Pc - 98.2 (wt.%). The spectral characteristics of
these components have been recorded by UV–vis
spectra at a SPECORD M400 Carl Zeiss Jena
spectrophotometer with double beam and
microprocessor using MgO as reference solid
powder. The following UV–vis λ/ε (nm/M−1.cm−1)values were obtained: (OH)AlS1Pc - 678/1x10
5;
(OH)AlS2Pc - 1.5x 10




Stock solutions of AlS2Pc (1.0x10−5 M) were routinely
prepared in PBS, and stored in the dark at 4°C. For
in vitro testing, solutions were prepared in culture media
and tested concentrations selected on a dose-effect
based curve previously explained [5].
Cell cultures and PDT
Human dysplastic oral keratinocytes, namely standard cell
line DOK (ECACC No. 94122104) were cultured in 5%
CO2 atmosphere at 37°C in DMEM medium (DMEDM,
Sigma-Aldrich, UK) with 2 mM Glutamine, 10% Fetal Calf
Serum (Sigma-Aldrich, UK), 5 μg/mL Hydrocortisone
(Sigma-Aldrich, UK) and 50U of Penicillin-Streptomycin
per 1 mL of cell culture medium (Sigma-Aldrich, UK).
Cells were incubated with AlS2Pc at a concentration of
4 μg/ml for 24 h and then irradiated with He-Ne laser
source λ = 632.8 nm), following an experimental protocol
detailed by the authors in a previous paper [4].
Apoptosis studies
Cellular apoptosis was verified using Annexin V-FITC
(Ann-FITC-green fluorescence) propidium iodide
(PI-red fluorescence) kit (BD Biosciences) by flow
cytometry. The early feature of apoptosis is characterized
by the translocation of the membrane phospholipid
phosphatidilserine from internal layer to the external layer
of cell membrane, this translocation being identified by
high affinity binding of Ann-FITC to phosphatidilserine. In
late apoptotic or necrotic cells in which phosphatidilserine
translocation has already occurred, the cell membrane is
damaged, and cells become double positive for Ann-FITC
and PI. Cell samples from the same batches that were
subjected to protein microarray analysis were immediately
analyzed in a FACScalibur cytometer (Becton Dickinson)
within 90 minutes, using Cell Quest software. Results are
presented as follows: percentage cells stained double
negative – live cells, double positive – dead/necrotic
cells and positive for Annexin, negative for propidium
iodide – apoptotic cells.
Protein microarray analysis
Cells incubated with AlS2Pc and control cells, incubated
in culture medium were analyzed by protein microarray
using Cancer/Apoptosis Phospho-Specific Array (Abnova),
an analysis kit suitable to detect 155 proteins involved
in apoptosis in both their phosphorylated and non-
phosphorylated forms. The slides contain antibodies
spotted in six replicates for each analyte to be detected,
the array being printed on standard-size coated micro-
scope glass. Briefly, after irradiation 1×106 cells from both
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to the kit instructions in order to obtain a cellular lysate
which was further purified and labeled with biotin. Prior
to coupling reaction and before adding the biotinylated
samples, slides were treated for blocking the unspecific
binding sites. The coupling reaction and detection with
Cy3-Streptavidin were performed afterward and both
slides representing control and respectively AlS2Pc treated
cells, were scanned using Full Substrate Spot Light
program (Molecular Devices), with a CCD scanner from
ArrayIt. Scanned TIFF images of slides were obtained and
further analyzed with Axon GenePix ProV7 software
(Molecular Devices), using for calculations the mean
values of recorded fluorescence for all spots replicates.
After data normalization, results were subjected to
statistical normality test with aid of Shapiro-Wilk and
Kolmogorov-Smirnov methods, followed by parametric/
non-parametric statistical comparison tests (t-test and
Mann–Whitney/Wilcoxon tests, respectively).
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